Clinical Trial Update: Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS [Phase 4]

View source ↗

Summary

Phase 4 trial suggests that preventive use of letrozole reduces the incidence of early-onset ovarian hyperstimulation syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: COMPLETED